1 – 5 of 5
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
2024) In Molecular Oncology(
- Contribution to journal › Article
- 2022
-
Mark
Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
(
- Contribution to journal › Article
- 2014
-
Mark
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
(
- Contribution to journal › Article
- 2001
-
Mark
Low frequency of E-cadherin alterations in familial breast cancer
(
- Contribution to journal › Article